Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Reports Q2 Revenues Growth

NEW YORK, Aug 2 (GenomeWeb News) - Paradigm Genetics posted on Monday a second-quarter net loss essentially flat with the year-ago quarter, despite a 12 percent rise in revenues during the period.

 

Paradigm's revenues in the quarter were $6.3 million, up from $5.6 million in the second quarter 2003.

 

Meanwhile, the company's research and development spending climbed to $6.8 million in the second quarter, compared with $6.5 million in the year-ago period, helping to drive overall expenses about $800,000 higher to $9.8 million.

 

Paradigm reported a second-quarter net loss of $3.6 million. As of June 30, the company had cash, cash equivalents, and short-term investments totaling about $10.7 million.

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.